Multiple Sclerosis

Multiple sclerosis (MS) is a severe autoimmune disease of the central nervous system that affects the brain and spinal cord, causing problems with muscle movement, balance and vision.

Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurodegenerative disorder that damages the nerves in the brain and spinal cord, leading to problems with muscle movement, balance and vision.

Multiple Sclerosis Epidemiology

Optic Neuritis and Multiple Sclerosis

Early Signs of Multiple Sclerosis

Multiple Sclerosis in Children

Multiple sclerosis and smoking

Multiple Sclerosis and Pregnancy

Multiple Sclerosis and Women’s Health

Types of Multiple Sclerosis (MS)

Epigenetics for Multiple Sclerosis

See more featured articles »

Secondary Progressive Multiple Sclerosis (SPMS)

What Causes Multiple Sclerosis?

Multiple sclerosis and beta interferon

Cognitive Impairment and Multiple Sclerosis

Benign Multiple Sclerosis (MS)

Anti-Myelin Antibodies in Multiple Sclerosis

At-Home Physiotherapy Exercises for Multiple Sclerosis

Working Towards Earlier Diagnosis of Multiple Sclerosis

Remyelination Strategies for Multiple Sclerosis

How is RRMS Different from PPMS and SPMS?

Primary Progressive Multiple Sclerosis (PPMS)

Heat Intolerance in Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis (RRMS)

Latest Multiple Sclerosis News and Research

Morning chronotype and exercise associated with reduced ALS risk

Being an early bird, also called a morning person, and being more physically active are associated with lower risks of amyotrophic lateral sclerosis (ALS), according to a preliminary study released February 25, 2026, that will be presented at the American Academy of Neurology's 78th Annual Meeting taking place April 18-22, 2026, in Chicago and online.

25 Feb 2026

Smoking status influences Parkinson's disease risk and mortality outcomes

A new study of smokers finds that currently smoking is associated with a lower risk of developing Parkinson's disease, but quitting smoking was associated with a lower risk of death.

25 Feb 2026

Study finds brain changes related to worse memory in football players with repetitive head impacts

In former college and professional football players, a new study has found higher levels of inflammation were associated with worse brain structure, which in turn was related to worse memory.

25 Feb 2026

New maps of mouse brains reveal patterns of myelin formation

Johns Hopkins scientists say they have used 3D imaging, special microscopes and artificial intelligence (AI) programs to construct new maps of mouse brains showing a precise location of more than 10 million cells called oligodendrocytes.

22 Feb 2026

Genome sequencing data reveals new insights into Epstein-Barr virus immunity

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown.

19 Feb 2026

Prenatal lead exposure linked to lower cognition six decades later

Exposure to lead before birth is associated with lower performance 60 years later on tests of thinking and memory skills in female participants, according to a study published on February 18, 2026, in Neurology, the medical journal of the American Academy of Neurology.

18 Feb 2026

Does Ginkgo biloba help dementia? New review examines the evidence

A major Cochrane review examines whether a widely used herbal supplement truly supports cognitive function, revealing modest dementia benefits but limited evidence for prevention or early impairment.

18 Feb 2026

Can GLP-1 drugs slow neurodegeneration? New review finds promising signals but limited clinical proof

This review examines how GLP-1 receptor agonists may influence neurodegenerative disease biology through metabolic, inflammatory, mitochondrial, and proteostasis pathways. Evidence from mechanistic, preclinical, and early clinical studies suggests potential neuroprotective effects, but definitive disease-modifying benefit remains unproven.

17 Feb 2026

Study reveals dynamic nature of myelin swellings

An international research team of Amsterdam UMC, VU LaserLab, the Netherlands Institute for Neuroscience and the University of Edinburgh have gained new insights into the dynamics of myelin swellings in the brain.

12 Feb 2026

Lifelong learning associated with lower risk of Alzheimer's disease

Engaging in a variety of intellectually stimulating activities throughout life, such as reading, writing and learning a language, is associated with a lower risk of Alzheimer's disease and slower cognitive decline, according to a new study published on February 11, 2026, in Neurology, the medical journal of the American Academy of Neurology.

11 Feb 2026

Traumatic brain injury linked to long-term work disability

Having a traumatic brain injury, no matter how serious, is associated with a greater likelihood of qualifying for work disability up to five years later, according to a study published February 11, 2026, in Neurology, the medical journal of the American Academy of Neurology.

11 Feb 2026

AI-powered tool automatically segments human brainstem white matter bundles

Small and dense but filled with vitally important neural fibers, the brainstem has been hard for brain imaging technologies to dissect.

9 Feb 2026

EBV-linked killer T cells implicated in multiple sclerosis

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million Americans.

5 Feb 2026

Mediterranean diet may protect women against all stroke types

Following a Mediterranean diet is associated with a lower risk of all types of stroke among women, according to a study published on February 4, 2026, in Neurology Open Access, an official journal of the American Academy of Neurology.

4 Feb 2026

Implantable immune scaffold predicts type 1 diabetes weeks before symptoms

The study highlights a presymptomatic phase in type 1 diabetes progression, using immune niches to track immune changes before blood sugar abnormalities.

4 Feb 2026

Antidepressant use does not worsen early outcomes after traumatic brain injury

Taking certain antidepressants at the time of a traumatic brain injury (TBI) is not associated with an increased risk of death, brain surgery or longer hospital stays, according to a study published on January 28, 2026, in Neurology, the medical journal of the American Academy of Neurology.

28 Jan 2026

Brain cell precursors show constant myelin-making drive

In experiments with mice, Johns Hopkins Medicine scientists report new evidence that precursors of myelin-producing cells - one of the few brain cell types that continue to be produced in the adult brain - undergo differentiation widely and at a constant pace, rather than "as needed" in response to injury or advancing age.

22 Jan 2026